U.S. Renewable Energy Stock News

If you are wondering whether Clean Harbors at around US$310 per share is still reasonably priced, the starting point is to understand how its current market value lines up with the underlying business. The stock has posted returns of 4.6% over the last 7 days, 8.8% over the past month, 27.5% year to date, 46.4% over 1 year, 115.1% over 3 years and 245.2% over 5 years. This naturally raises questions about how expectations and risk are being priced in today. Recent headlines have focused on...

Why Amicus Therapeutics is on investors’ radar today Amicus Therapeutics (FOLD) has caught investor attention after recent performance data showed modest positive returns over the past month and past 3 months, prompting closer focus on how its rare disease portfolio supports the current valuation. See our latest analysis for Amicus Therapeutics. At a share price of $14.46, Amicus Therapeutics shows only modest short term share price returns. The 1 year total shareholder return of 100.83%...

Western Alliance Bancorporation (NYSE:WAL) addressed two significant fraud-related loan charge-offs in Q1 2026, which management believes helps clear legacy credit risk. The bank reported $5.6b in Q1 deposit growth and plans to shift from aggressive deposit gathering to a more balanced growth approach. These moves are intended to refine Western Alliance's risk management and funding profile following a period of strong deposit inflows. Western Alliance Bancorporation enters this shift with...

Investors may be wondering whether Cytokinetics at around US$65.48 is still offering value, or if most of the upside is already reflected in the price. The stock has returned 0.1% over the last week, 9.1% over the past 30 days, 6.1% year to date and 62.4% over the last year, with longer term returns of 73.0% over 3 years and 148.1% over 5 years. Recent coverage has focused on Cytokinetics as a biotech name that investors are watching closely, with attention on how its pipeline and...

Corpay Cross-Border, part of NYSE:CPAY, has entered a new partnership with Toulouse Football Club as the club's Official FX Supplier. The agreement extends Corpay's reach in European football, following its previously announced relationship with AC Milan. The deal focuses on supporting Toulouse FC's international payment and currency risk management needs. For readers tracking NYSE:CPAY, this Toulouse FC partnership adds another high profile sports relationship to Corpay's cross border...

Immunome plans to present full Phase 3 RINGSIDE trial data for varegacestat in desmoid tumor patients at the 2026 ASCO Annual Meeting. The company expects to file a New Drug Application with the FDA for varegacestat after the ASCO presentation. The update highlights progress toward a potential new treatment option for this rare soft tissue tumor. For investors tracking Immunome, ticker NasdaqCM:IMNM, this update centers on a late stage program that could influence the company’s future...

If you are wondering whether Molson Coors Beverage is attractively priced at around US$42.87, the key is understanding what you are getting for that share price today. The stock has been under pressure over longer periods, with a 23.6% decline over the last year and a 9.6% drop year to date, although it has risen 4.2% over the past month while slipping 2.9% in the last week. Recent news flow around Molson Coors has focused on its position in the beverage sector and how investors are weighing...

Betterware de México, S.A.P.I. de C.V. reported past first-quarter 2026 results with sales of MX$3,509.7 million, slightly above the prior year’s MX$3,499.15 million, and net income of MX$281.34 million versus MX$151.39 million. The sharp improvement in profit despite broadly flat revenue suggests the company has recently become more efficient in converting sales into earnings. Next, we’ll examine how this stronger profitability trend could influence Betterware de México’s investment...

The market has been flat over the last week, but it's up 30% over the past year, with earnings forecast to grow by 16% annually. For investors willing to explore beyond established giants, penny stocks can offer a unique blend of affordability and growth potential. Despite their vintage name, these smaller or newer companies can present compelling opportunities when backed by solid financials.

The United States market has experienced a flat trajectory over the past week, yet it has achieved an impressive 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying dividend stocks that offer consistent income and potential for growth can be a strategic approach for investors seeking stability and returns.

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see OceanFirst...

Some JPMorgan Chase & Co. ( NYSE:JPM ) shareholders may be a little concerned to see that the Chairman & CEO, James...

The fact that multiple Franklin Electric Co., Inc. ( NASDAQ:FELE ) insiders offloaded a considerable amount of shares...

If you are wondering whether Trex Company at around US$42.37 is priced for a comeback or still carrying too much past baggage, the starting point is understanding what the current market price actually reflects about its fundamentals. The stock is up 3.0% over the last week and 15.4% over the last month, while year to date it is up 18.3% yet still shows a 28.3% decline over the past year and a 61.2% decline over five years. Recent coverage has focused on how Trex Company fits into broader...

Southwest Airlines (LUV) has just opened 2026 with Q1 operating metrics that put capacity and pricing in focus, reporting 67,669 million Available Seat Kilometers flown, a passenger load factor of 74.1%, and a revenue yield of US$10.71 per ASK. The trailing twelve months to Q4 2025 show total revenue of US$28.1 billion, EPS of US$0.82, and net income of US$441 million. Over the past few quarters, revenue has ranged from US$6.4 billion in Q1 2025 to US$7.4 billion in Q4 2025 as EPS moved from...

Bright Horizons Family Solutions (NYSE:BFAM) released its 2025 Education Index, highlighting significant gaps in workforce AI skills. Data from the company’s EdAssist program shows many employees feel unprepared for AI, even as 42% expect substantial AI related changes to their jobs within a year. The findings emphasize growing employee expectations for employer funded AI training and education benefits. For investors watching NYSE:BFAM, this update puts fresh attention on the company’s...

Meritage Homes (MTH) has just laid out a fresh set of numbers for Q1 2026 against a backdrop where trailing twelve month revenue sits at about US$5.9b and basic EPS for the same period is US$6.40, with trailing net margin of 7.7% versus 12.3% a year earlier. Over the last reported quarters, revenue in individual periods has ranged from US$1.36b to US$1.63b while basic EPS has moved between US$1.21 and US$2.71. This gives investors a clear view of how top line scale and per share earnings have...

If you are wondering whether Everest Group at US$350.81 is offering fair value or a potential bargain, the key is to look past the headline price and into how it stacks up on several valuation checks. Over shorter periods the stock has had mixed results, with returns of 1.9% over 7 days, 8.4% over 30 days, 4.9% year to date, 1.2% over 1 year, flat over 3 years and 43.5% over 5 years. This may have shifted how investors view its growth potential and risk. Recent coverage has focused on...

If you are wondering whether Concentrix at around US$26.78 is a bargain or a value trap, the key lies in understanding how its current price lines up with different valuation checks. The stock has seen a 9.5% decline over the last 7 days, sits roughly flat over 30 days with a 1.1% gain, and is still showing heavier falls of 35.0% year to date and 45.3% over the past year. Those moves come after a much longer slide, with 3 year returns of 70.1% and 5 year returns of 81.6%. This keeps many...

Recent trading context for Sila Realty Trust Sila Realty Trust (SILA) has drawn fresh attention after a recent move in its share price, with the stock last closing at $30.40 and showing double digit returns over the past month. For investors watching healthcare focused real estate, the trust’s recent share performance, its US$1.68b market value and current financial profile provide a starting point for assessing how its net lease model fits into a diversified income portfolio. See our latest...

If you are wondering whether Ionis Pharmaceuticals at around US$74.09 is priced for more growth or already reflects the story, the key is to look carefully at what the current valuation actually implies. The stock has had a mixed recent run, with a 1.6% decline over the last 7 days, a 6.3% gain over the past month, a 7.0% decline year to date, and a 150.6% return over the last year that may have reshaped expectations and perceived risk. Recent coverage around Ionis has focused on its...

Louisiana-Pacific (NYSE:LPX) announced a new partnership with the Ruffed Grouse Society and American Woodcock Society to support sustainable forest management and wildlife habitat projects in the Upper Midwest. The collaboration focuses on working with private landowners to improve ecological outcomes and help support long term wood fiber supply for the company. For investors tracking NYSE:LPX, this environmental partnership arrives with the stock at $74.7 and a value score of 1. The share...

Liberty Energy (LBRT) has put fresh numbers on the table for Q1 2026, with revenue of $1.0b, basic EPS of $0.14 and net income of $22.6 million setting the tone for the latest update. Over the past year, the company has seen quarterly revenue move between $943.6 million and $1.0b while basic EPS has ranged from $0.08 to $0.44. This gives investors a clearer view of how the top line and per share earnings have tracked into the current print. With revenue still presented in the context of...

Wondering whether Green Brick Partners at around US$71.84 is still offering value, or if most of the upside is already reflected in the share price. The stock has logged returns of 9.4% over 7 days, 13.6% over 30 days, 13.7% year to date and 23.9% over the last year, with longer term figures of 95.0% over 3 years and 170.3% over 5 years giving extra context to the recent move. Recent attention around Green Brick Partners has focused on the homebuilding space, with investors weighing how...